Hypermutation induced by APOBEC-1 overexpression can be eliminated

RNA

Volumn 16, Issue 5, 2010, Pages 1040-1052

  Chen, Zhigang ^a   Eggerman, Thomas L ^a,b   Bocharov, Alexander V ^a   Baranova, Irina N ^a   Vishnyakova, Tatyana G ^a   Csako, Gyorgy ^a   Patterson, Amy P ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

ACF; APOBEC 1; Apolipoprotein; Editing; Hyperediting; Hypermutation

Indexed keywords

ACF PROTEIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; MESSENGER RNA; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER; LIVER CELL; MUTANT; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SITE DIRECTED MUTAGENESIS; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; APOLIPOPROTEINS B; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; CYTIDINE DEAMINASE; DNA PRIMERS; GENE EXPRESSION; HEPATOCYTES; HUMANS; ISOENZYMES; MUTAGENESIS, SITE-DIRECTED; MUTATION; RATS; RECOMBINANT PROTEINS; RNA EDITING; RNA, MESSENGER; RNA-BINDING PROTEINS;

ANIMALIA; RATTUS;

EID: 77951165117     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.1863010     Document Type: Article

References (33)

1. Anant S, Blanc V, Davidson NO. 2003. Molecular regulation, evolutionary, and functional adaptations associated with C-to-U editing of mammalian apolipoproteinB mRNA. Prog Nucleic Acid Res Mol Biol 75: 1-41.
2. Blanc V, Kennedy S, Davidson NO. 2003. A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling. J Biol Chem 278: 41198-41204.
3. Bocharov AV, Huang W, Vishniakova TG, Zaitseva EV, Frolova EG, Rampal P, Bertolotti R. 1995. Glucocorticoids upregulate high-affinity, high-density lipoprotein binding sites in rat hepatocytes. Metabolism 44: 730-738.
4. Chan L. 1992. Apolipoprotein B, the major protein component of triglyceride-rich and low-density lipoproteins. J Biol Chem 267: 25621-25624.
5. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, et al. 1987. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238: 363-366.
6. Chen Z, Eggerman TL, Patterson AP. 2007. ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components. Am J Physiol Gastrointest Liver Physiol 292: G53-G65.
7. Chester A, Somasekaram A, Tzimina M, Jarmuz A, Gisbourne J, O'Keefe R, Scott J, Navaratnam N. 2003. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay. EMBO J 22: 3971-3982.
8. Chester A, Weinreb V, Carter CW Jr, Navaratnam N. 2004. Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF. RNA 10: 1399-1411.
9. Funahashi T, Giannoni F, DePaoli AM, Skarosi SF, Davidson NO. 1995. Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: Functional role in the modulation of apoB mRNA editing. J Lipid Res 36: 414-428.
10. Hersberger M, Innerarity TL. 1998. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J Biol Chem 273: 9435-9442.
11. Hersberger M, Patarroyo-White S, Qian X, Arnold KS, Rohrer L, Balestra ME, Innerarity TL. 2003. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting. Biochem J 369: 255-262.
12. Hughes SD, Rouy D, Navaratnam N, Scott J, Rubin EM. 1996. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits. Hum Gene Ther 7: 39-49.
13. Innerarity TL, Mahley RW. 1978. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low-density lipoproteins. Biochemistry 17: 1440-1447.
14. Innerarity TL, Boren J, Yamanaka S, Olofsson SO. 1996. Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J Biol Chem 271: 2353-2356.
15. Kozarsky KF, Bonen DK, Giannoni F, Funahashi T, Wilson JM, Davidson NO. 1996. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther 7: 943-957.
16. Maris C, Masse J, Chester A, Navaratnam N, Allain FH. 2005. NMR structure of the apoB mRNA stem-loop and its interaction with the C-to-U editing APOBEC1 complementary factor. RNA 11: 173-186.
17. Patterson AP, Chen Z, Rubin DC, Moucadel V, Iovanna JL, Brewer HB Jr, Eggerman TL. 2003. Developmental regulation of apolipoprotein B mRNA editing is an autonomous function of small intestine involving homeobox gene Cdx1. J Biol Chem 278: 7600-7606.
18. Pitas RE, Innerarity TL, Mahley RW. 1980. Cell surface receptor binding of phospholipid. protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J Biol Chem 255: 5454-5460.
19. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. 1987. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50: 831-840.
20. Qian X, Balestra ME, Yamanaka S, Boren J, Lee I, Innerarity TL. 1998. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Arterioscler Thromb Vasc Biol 18: 1013-1020.
21. Siddiqui JF, Van Mater D, Sowden MP, Smith HC. 1999. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity. Exp Cell Res 252: 154-164.
22. Smedsrod B, Pertoft H, Eggertsen G, Sundstrom C. 1985. Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cells prepared by means of density separation in Percoll, and selective substrate adherence. Cell Tissue Res 241: 639-649.
23. Sowden M, Hamm JK, Smith HC. 1996a. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J Biol Chem 271: 3011-3017.
24. Sowden M, Hamm JK, Spinelli S, Smith HC. 1996b. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs. RNA 2: 274-288.
25. Sowden MP, Eagleton MJ, Smith HC. 1998. Apolipoprotein B RNA sequence 39 of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing. Nucleic Acids Res 26: 1644-1652.
26. Teng B, Blumenthal S, Forte T, Navaratnam N, Scott J, Gotto AM Jr, Chan L. 1994. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem 269: 29395-29404. (Pubitemid 24987930)
27. Teng B, Ishida B, Forte TM, Blumenthal S, Song LZ, Gotto AM Jr, Chan L. 1997. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1). Arterioscler Thromb Vasc Biol 17: 889-897.
28. Teng BB, Ochsner S, Zhang Q, Soman KV, Lau PP, Chan L. 1999. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization. J Lipid Res 40: 623-635.
29. Yamanaka S, Poksay KS, Balestra ME, Zeng GQ, Innerarity TL. 1994. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J Biol Chem 269: 21725-21734.
30. Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, Taylor JM, Innerarity TL. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci 92: 8483-8487.
31. Yamanaka S, Poksay KS, Driscoll DM, Innerarity TL. 1996. Hyper-editing of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem 271: 11506-11510.
32. Yamanaka S, Poksay KS, Arnold KS, Innerarity TL. 1997. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes & Dev 11: 321-333.
33. Young SG. 1990. Recent progress in understanding apolipoprotein B. Circulation 82: 1574-1594.